238 related articles for article (PubMed ID: 15723841)
1. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue.
Ding H; Wang WP; Huang BJ; Wei RX; He NA; Qi Q; Li CL
J Ultrasound Med; 2005 Mar; 24(3):285-97. PubMed ID: 15723841
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
3. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
4. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
5. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
8. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
von Herbay A; Vogt C; Willers R; Häussinger D
J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
[TBL] [Abstract][Full Text] [Related]
9. Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography.
Wang WP; Ding H; Qi Q; Mao F; Xu ZZ; Kudo M
World J Gastroenterol; 2003 Aug; 9(8):1667-74. PubMed ID: 12918098
[TBL] [Abstract][Full Text] [Related]
10. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions.
Youk JH; Kim CS; Lee JM
J Ultrasound Med; 2003 Sep; 22(9):897-910. PubMed ID: 14510261
[TBL] [Abstract][Full Text] [Related]
12. Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT.
Passamonti M; Vercelli A; Azzaretti A; Rodolico G; Calliada F
Radiol Med; 2005 Apr; 109(4):358-69. PubMed ID: 15883520
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and differential diagnosis of liver abscesses using contrast-enhanced (SonoVue) ultrasonography].
Fontanilla Echeveste T; Mendo González M; Cañas Maciá T; Pérez Arangüena R; Velasco Marcos MJ; Cortés León C
Radiologia; 2009; 51(4):403-10. PubMed ID: 19539338
[TBL] [Abstract][Full Text] [Related]
14. Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas.
Li R; Zhang X; Hua X; Cai P; Zhong H; Guo Y; Ding S; Yan X
Abdom Imaging; 2010 Dec; 35(6):676-82. PubMed ID: 20020286
[TBL] [Abstract][Full Text] [Related]
15. [Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease].
Gómez Rodríguez RA; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; Repiso Ortega A; Pérez-Grueso Macías MJ; Muñoz Rosas C; Carrobles Jiménez JM
Gastroenterol Hepatol; 2007; 30(7):381-6. PubMed ID: 17692194
[TBL] [Abstract][Full Text] [Related]
16. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions.
Liu GJ; Lu MD; Xie XY; Xu HX; Xu ZF; Zheng YL; Liang JY; Wang W
J Ultrasound Med; 2008 Apr; 27(4):657-66. PubMed ID: 18359914
[TBL] [Abstract][Full Text] [Related]
17. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
[TBL] [Abstract][Full Text] [Related]
18. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions.
Nicolau C; Vilana R; Catalá V; Bianchi L; Gilabert R; García A; Brú C
AJR Am J Roentgenol; 2006 Jan; 186(1):158-67. PubMed ID: 16357396
[TBL] [Abstract][Full Text] [Related]
19. [Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions].
Strunk H; Börner N; Stuckmann G; Fröhlich E; Hadizadeh D
Rofo; 2005 Oct; 177(10):1394-404. PubMed ID: 16170709
[TBL] [Abstract][Full Text] [Related]
20. Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography.
Bartolotta TV; Midiri M; Quaia E; Bertolotto M; Galia M; Cademartiri F; Lagalla R; Cardinale AE
Eur Radiol; 2005 Aug; 15(8):1643-9. PubMed ID: 15712000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
